The largest database of trusted experimental protocols

6 protocols using rg088s

1

TGF-βR1 Promoter Luciferase Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The procedure was performed according to the manufacturer’s instructions (RG088S, Beyotime, China). Briefly, HEK293T cells were transfected with ERα plasmid or its empty vector control in combination with pTGF-βR1-Luc reporter construct, pRL-TK, and E2 and incubated for 48 h. Next, the cells were lysed using the detection buffer for 15 min. The supernatant of the lysate was used to measure the expression of the luciferase reporter gene. The activity of pTGF-βR1-Luc was normalized with the transfection efficiency using the activity of Renilla luciferase (pRL-TK). To generate luciferase reporter plasmids of TGF-βRIpromoter, DNA fragments (predicted ERE sequence: TCAAATTTAGTCTCTGTAGCCTCGGTGC; Mut ERE sequence: TCTTAACTCATGACAGTACGTATCTCGGTGC) were synthesized and inserted into the pGL3 basic luciferase expression vector (Promega, Madison, WI, USA). HEK293T cells were transfected using luciferase reporter plasmids. The luciferase activity reflected the transcriptional activity of the target genes. To assay the luciferase activity, cell extracts were detected on the Dual-Luciferase Reporter (DLR) assay system (Promega).
+ Open protocol
+ Expand
2

Validation of MTDH-miR-9-3p Interaction

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 3′UTR of MTDH sequence of the site binding to miR-9-3p was inserted into a pmirGLO dual-luciferase vector with XhoI and XbaI double digestion to construct the generative wildtype (WT) MTDH. The Site-Directed Mutagenesis Kit was used to synthesize the mutant (MUT) MTDH sequence and then inserted into the pmirGLO dual-luciferase vector with XhoI and XbaI double. Next, the pmirGLO vector containing WT or MUT MTDH sequence was respectively co-transfected with miR-9-3p mimic into HEK293T cells using Lipofectamine 2000 (Invitrogen, USA). After incubation for 48 h, a dual-luciferase reporter gene detection kit (RG088S, Beyotime Biotechnology, China) was used to measure the relative luciferase activity of the cells.
+ Open protocol
+ Expand
3

Validating miR-340-5p binding to TNFSF8 3'UTR

Check if the same lab product or an alternative is used in the 5 most similar protocols
Jefferson software (http://www.jefferson.edu/) was used to predict the possible binding site of miR-340-5p with the TNFSF8 3′UTR. The TNFSF8 wild-type (Wt) and mutant (Mt) 3′-UTR sequences were synthesized and inserted into a psiCHECK2 plasmid to produce a wild-type TNFSF8 (WT-TNFSF8) luciferase reporter plasmid and mutant TNFSF8 (mut-TNFSF8) luciferase reporter plasmid. Subsequently, a miR-483-5p mimic or mimic-NC was cotransfected with the WT-TNFSF8 reporter or Mut-TNFSF8 reporter plasmid using a Lipofectamine 3000 kit (Invitrogen, Cat. 11668-027, CA, USA). After 48 h, the luciferase activity was measured using a dual-luciferase reporter assay kit (Beyotime, Cat. RG088S, Shanghai).
+ Open protocol
+ Expand
4

Transcriptional Activity Assay in HEK293T

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T cells (8000 per well) were seeded on 96‐well white plates and transfected with 50 ng of the indicated firefly luciferase reporter gene plasmid or (and) 50 ng of transcription factor (CREB or CREBS133A) plasmid, while the renal luciferase plasmid (5 ng per well) was also transfected as an internal control. After cotransfection for 48 h, the plates were placed at room temperature for 10 min, and 100 µL of firefly or Renilla luciferase substrate (RG088S, Beyotime) was added and incubated for 5 min each. The RLU, reflecting chemiluminiscence, were determined by a microplate reader, and the ratio of firefly to Renilla RLU was calculated for comparison between groups.
+ Open protocol
+ Expand
5

PD-L1 Promoter Luciferase Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human PD-L1 promoter region1 (−534/0 bp), region2 (0/593 bp) and region3 (−207/ + 134 bp) was synthesized and subcloned into the promoterless basic pGL4.10[luc2] vector (Promega) to generate pGL4.10-PD-L1p-4.0-[luc2]. Promoterless pGL4.10 [luc2] and pGL4.74[hRluc] vectors (Promega) served respectively as negative and internal controls. HEK293T cells were plated on 24-well plates at 1 × 105 cells/well one day before transient transfection. Co-transfection groups included basic pGL4.10[luc2] vector or pGL4.10-PD-L1p-4.0-[luc2] (800 ng/well), empty vector (EV) or GATA2 overexpression lentiviral vector (800 ng/well), and pGL4.74[hRluc] (50 ng/well). These vectors were cotransfected into 293 T cells using PEI 40 K (Polyscience). After 48 h, the luciferase activities were determined using a dual-luciferase reporter assay kit (RG088S, Beyotime Biotechnology) following the manufacturer’s instructions and measured by BioTek Synergy H4 Hybrid Microplate Reader. The firefly luciferase activity was normalized to Renilla luciferase for each well, and each sample was analyzed in duplicate.
+ Open protocol
+ Expand
6

TRIM7 Regulation of IFN-β Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T cells (1×104/well, 96-well white plate) stably expressed TRIM7/TRIM7-mut or EGFP were co-transfected with 20-80 ng of indicated expression plasmids or empty vector, and luciferase plasmid cocktail containing 10 ng of IFN-β-firefly-luc plasmid (IFN-β promoterdriven firefly luciferase plasmid) and 5 ng of pTracer-Renilla-luc plasmid (luciferase control plasmid). Cells were stimulated by co-transfection with 10 ng of pcDNA3-RIG-I (2CARD) plasmids, and empty pcDNA3 vector was used as unstimulated control. Lipofectamine 3000 reagent (Invitrogen, L3000001) was used to transfect these plasmids. 24 h post-transfection, the cells were assayed for dual-luciferase assay activities according to the manufacturer's instructions (Beyotime, RG088S).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!